SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-057663
Filing Date
2018-11-06
Accepted
2018-11-06 17:02:25
Documents
63
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv505322_10q.htm 10-Q 792642
2 EXHIBIT 31.1 tv505322_ex31-1.htm EX-31.1 12448
3 EXHIBIT 31.2 tv505322_ex31-2.htm EX-31.2 12445
4 EXHIBIT 32.1 tv505322_ex32-1.htm EX-32.1 4486
5 EXHIBIT 32.2 tv505322_ex32-2.htm EX-32.2 4493
12 GRAPHIC tv505322_img-01.jpg GRAPHIC 84444
13 GRAPHIC tv505322_img-02.jpg GRAPHIC 124888
  Complete submission text file 0001144204-18-057663.txt   6681974

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT iova-20180930.xml EX-101.INS 1862292
7 XBRL TAXONOMY EXTENSION SCHEMA iova-20180930.xsd EX-101.SCH 40155
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iova-20180930_cal.xml EX-101.CAL 28890
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iova-20180930_def.xml EX-101.DEF 292100
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE iova-20180930_lab.xml EX-101.LAB 293029
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iova-20180930_pre.xml EX-101.PRE 321876
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36860 | Film No.: 181163833
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1